Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Team Grant: Indirect Socio-Economic Burden of Inherited Diseases

Unity Health Toronto

$449,610.00

Variations in care for hereditary cancer syndrome families: direct and indirect socio-economic impacts

EF 2021-22

Résumé
Patients at risk for a hereditary cancer syndrome (HCS) require complex care over a lifetime. HCS care across Canada is fragmented due to variation in access to genetic testing and high risk follow up. These systemic variations result in indirect social and economic impacts on HCS patients and families. Yet, the indirect burden of HCS is often unaccounted for and underestimated. There is a need to map these indirect socio-economic impacts of the variations in systems of care for patients with suspected and confirmed inherited cancer syndromes across Canada. First, we will explore indirect social and economic impacts of current systems of HCS care using multigene panel testing. We will conduct interviews and a cross-sectional survey among patients with HCS from Newfoundland and Labrador (NL), British Columbia (BC) and Ontario (ON). We will examine outcomes related to care (e.g., wait times, access), psychosocial impacts (e.g., discrimination, distress), and economic impacts (e.g., out-of-pocket and travel costs) associated with HCS. Next, we will assess direct and indirect socioeconomic impacts of genomic sequencing (future state of HCS care) and incidental findings (IFs, results unrelated to HCS) for HCS patients. We will conduct interviews, evaluate patient-reported outcomes and an economic evaluation, building on a recent randomized controlled trial (RCT) among patients with suspected HCS. We will assess outcomes related to care (e.g., follow-up management), psychosocial impacts (e.g., career, reproductive decisions) and economic impacts associated with genomic sequencing and IFs (e.g., to the health care system and patients). This study will examine the direct and indirect socioeconomic and psychological impacts of HCS on patients and families. Comparing among NL, BC and ON will allow us to identify provincial differences in the indirect socioeconomic burden of HCS, to inform policy, health care and social system interventions to mitigate inequities.
Programme
Team Grant: Indirect Socio-Economic Burden of Inherited Diseases
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
446818
Name
Bombard Yvonne
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Team Grant: Indirect Socio-Economic Burden of Inherited Diseases
Projecttitle
Variations in care for hereditary cancer syndrome families: direct and indirect socio-economic impacts
Programtype2
Operating Grants
Orgnameinp2
Unity Health Toronto
Cihramount2
$449,610
Cihrequipment2
$0
Programname2
Team Grant: Indirect Socio-Economic Burden of Inherited Diseases
Keyworddelim
Genetic Testing; Genomic Sequencing; Hereditary Cancer; Indirect Impacts Of Disease
Abstract
Patients at risk for a hereditary cancer syndrome (HCS) require complex care over a lifetime. HCS care across Canada is fragmented due to variation in access to genetic testing and high risk follow up. These systemic variations result in indirect social and economic impacts on HCS patients and families. Yet, the indirect burden of HCS is often unaccounted for and underestimated. There is a need to map these indirect socio-economic impacts of the variations in systems of care for patients with suspected and confirmed inherited cancer syndromes across Canada. First, we will explore indirect social and economic impacts of current systems of HCS care using multigene panel testing. We will conduct interviews and a cross-sectional survey among patients with HCS from Newfoundland and Labrador (NL), British Columbia (BC) and Ontario (ON). We will examine outcomes related to care (e.g., wait times, access), psychosocial impacts (e.g., discrimination, distress), and economic impacts (e.g., out-of-pocket and travel costs) associated with HCS. Next, we will assess direct and indirect socioeconomic impacts of genomic sequencing (future state of HCS care) and incidental findings (IFs, results unrelated to HCS) for HCS patients. We will conduct interviews, evaluate patient-reported outcomes and an economic evaluation, building on a recent randomized controlled trial (RCT) among patients with suspected HCS. We will assess outcomes related to care (e.g., follow-up management), psychosocial impacts (e.g., career, reproductive decisions) and economic impacts associated with genomic sequencing and IFs (e.g., to the health care system and patients). This study will examine the direct and indirect socioeconomic and psychological impacts of HCS on patients and families. Comparing among NL, BC and ON will allow us to identify provincial differences in the indirect socioeconomic burden of HCS, to inform policy, health care and social system interventions to mitigate inequities.
Competitiondate
202105
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bombard, Yvonne; Sun, Sophie; Etchegary, Holly; Schrader, Kasmintan A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $449,610~ $0~